Repligen Reports First Quarter 2020 Financial ResultsĀ and Updates Full Year 2020 Financial Guidance

Go back to Repligen Reports First Quarter 2020 Financial ResultsĀ and Updates Full Year 2020 Financial Guidance

Repligen (RGEN) Tops Q1 EPS by 11c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, Reaffirms Revenue Views Above Consensus

May 6, 2020 7:42 AM EDT

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.32, $0.11 better than the analyst estimate of $0.21. Revenue for the quarter came in at $76.1 million versus the consensus estimate of $71.19 million.

Financial Highlights for the First Quarter 2020

Revenue increased by 25% year-over-year as reported and 16% organically, to $76.1 millionGAAP gross margin increased to 58.0%, a year-over-year increase of 220 bpsAdjusted gross margin (non-GAAP) increased to 58.5%, a year-over-year increase of 250 bpsGAAP fully diluted EPS increased to $0.18 compared to $0.17 for the first quarter of 2019Adjusted fully diluted EPS (non-GAAP) increased to $0.32 compared to $0.26 for... More